Literature DB >> 24171180

Sleep disturbance in patients with burning mouth syndrome: a case-control study.

Daniela Adamo, Vittorio Schiavone, Massimo Aria, Stefania Leuci, Elvira Ruoppo, Giovanni Dell'Aversana, Michelle D Mignogna.   

Abstract

AIM: To examine sleep complaints in patients with burning mouth syndrome (BMS) and the relationships between these disturbances, negative mood, and pain.
METHODS: Fifty BMS patients were compared with an equal number of healthy controls matched for age, sex, and educational level. The Pittsburgh Sleep Quality Index (PSQI), the Epworth Sleepiness Scale (ESS), the Hamilton Rating Scales for Depression (HAM-D) and Anxiety (HAM-A) were administered. Descriptive statistics, including the Mann-Whitney U test and hierarchical multiple linear regression analyses were used.
RESULTS: BMS patients had higher scores in all items of the PSQI and ESS than the healthy controls (P < .001). In the BMS patients, a depressed mood and anxiety correlated positively with sleep disturbances. The Pearson correlations were 0.68 for PSQI vs HAM-D (P < .001) and 0.63 for PSQI vs HAM-A (P < .001).
CONCLUSION: BMS patients reported a greater degree of sleep disorders, anxiety, and depression as compared with controls. Sleep disorders could influence quality of life of BMS patients and could be a possible treatment target.

Entities:  

Mesh:

Year:  2013        PMID: 24171180     DOI: 10.11607/jop.1109

Source DB:  PubMed          Journal:  J Orofac Pain        ISSN: 1064-6655


  4 in total

1.  Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study.

Authors:  Yves Boucher; Adeline Braud; Evelyne Dufour; Scarlette Agbo-Godeau; Vanessa Baaroun; Vianney Descroix; Marie-Thérèse Guinnepain; Marie-Noëlle Ungeheuer; Catherine Ottone; Catherine Rougeot
Journal:  Clin Oral Investig       Date:  2016-11-10       Impact factor: 3.573

2.  The analgesic effect of therapeutic rTMS is not mediated or predicted by comorbid psychiatric or sleep disorders.

Authors:  Pauliina Lindholm; Salla Lamusuo; Tero Taiminen; Arja Virtanen; Antti Pertovaara; Heli Forssell; Nora Hagelberg; Satu Jääskeläinen
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

3.  Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome.

Authors:  Jacek Zborowski; Tomasz Konopka
Journal:  Int J Environ Res Public Health       Date:  2022-07-24       Impact factor: 4.614

4.  Low-level laser therapy in patients with Burning Mouth Syndrome: A double-blind, randomized, controlled clinical trial.

Authors:  Juliana-Cassol Spanemberg; Juan-Jose Segura-Egea; Eugenia Rodríguez-de Rivera-Campillo; Enric Jané-Salas; Fernanda-Gonçalves Salum; Jose López-López
Journal:  J Clin Exp Dent       Date:  2019-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.